Since retatrutide does not directly stimulate androgen production, it does not carry the risk of virilization or masculinization in female subjects
Additionally, prominent pharmacy benefit managers and insurers are increasingly including Zepbound in formularies, improving patient affordability and uptake
In this regard, it is noteworthy that a selective glucagon receptor antagonist increased hepatic fat in patients with T2D 23
S., Khanlarkhani, N., Khezri, Z., Majidpoor, J., Abouzaripour, M., Habibi, M., Kashani, I
Importantly, exogenous GLP-1 receptor agonist treatment suppressed both appetite and weight, opening opportunities for direct translation into the clinical setting
Concentration options for micro-dosing precision Three concentrations dominate practical microdosing